Ignite Creation Date:
2024-05-06 @ 3:41 PM
Last Modification Date:
2024-10-26 @ 1:54 PM
Study NCT ID:
NCT04715737
Status:
COMPLETED
Last Update Posted:
2021-01-22
First Post:
2021-01-14
Brief Title:
Differential Effects of Vasopressin and Oxytocin on Attention Control
Sponsor:
University of Electronic Science and Technology of China
Organization:
University of Electronic Science and Technology of China
Study Overview
Official Title:
The Differential Effects of Intranasal Vasopressin and Oxytocin on Attention Control
Status:
COMPLETED
Status Verified Date:
2021-01
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The main aim of the present study is to investigate whether intranasal vasopressin 20IU and oxytocin 24IU have differential effects on attention control in a social-emotional saccadeantisaccade eye-tracking paradigm
Detailed Description:
Previous studies have demonstrated intranasal vasopressin and oxytocins divergent effects on social behavior and emotion processing such as empathy and negative emotion processing however it remains unclear whether vasopressin and oxytocin treatment would have differential effects on attention processing to social stimuli Based on the previous registered studies ClinicalTrialsgov ID NCT04493554 and NCT03486925 from our group using a validated emotional anti-saccade task with social stimuli emotional faces and non-social stimuli oval shape have separately explored intranasal vasopressin and oxytocins modulatory effects on attention processing the present study aims to conduct a secondary analysis of the previously acquired data to directly compare vasopressin and oxytocins effects on attention control to social emotional stimuli To this end data from subjects who underwent intranasal oxytocin administration n 33 NCT03486925 will be compared with data from subjects who underwent intranasal vasopressin or placebo administration n 39 or 45 respectively NCT04493554 To further control for non-treatment related factors the intranasal placebo groups from the previous studies ClinicalTrialsgov ID NCT04493554 and NCT03486925 will be compared with respect to primary and secondary outcome measures of the trial in particular general and emotion-specific effects on attentional control
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None